Biogen Inc (BIIB)
157.84
-0.17
(-0.11%)
USD |
NASDAQ |
Nov 22, 16:00
158.00
+0.16
(+0.10%)
After-Hours: 18:54
Biogen Revenue (Annual): 9.836B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.836B |
| December 31, 2022 | 10.17B |
| December 31, 2021 | 10.98B |
| December 31, 2020 | 13.44B |
| December 31, 2019 | 14.38B |
| December 31, 2018 | 13.45B |
| December 31, 2017 | 12.27B |
| December 31, 2016 | 11.45B |
| December 31, 2015 | 10.76B |
| December 31, 2014 | 9.703B |
| December 31, 2013 | 6.932B |
| December 31, 2012 | 5.516B |
| December 31, 2011 | 5.049B |
| December 31, 2010 | 4.716B |
| December 31, 2009 | 4.377B |
| December 31, 2008 | 4.098B |
| December 31, 2007 | 3.172B |
| December 31, 2006 | 2.683B |
| December 31, 2005 | 1.714B |
| December 31, 2004 | 1.596B |
| Date | Value |
|---|---|
| December 31, 2003 | 186.13M |
| December 31, 2002 | 404.22M |
| December 31, 2001 | 1.042B |
| December 31, 2000 | 925.66M |
| December 31, 1999 | 794.44M |
| December 31, 1998 | 557.59M |
| December 31, 1997 | 434.04M |
| December 31, 1996 | 277.09M |
| December 31, 1995 | 151.69M |
| December 31, 1994 | 156.34M |
| December 31, 1993 | 136.40M |
| December 31, 1992 | 123.70M |
| December 31, 1991 | 61.40M |
| December 31, 1990 | 50.10M |
| December 31, 1989 | 28.50M |
| December 31, 1988 | 20.60M |
| December 31, 1987 | 8.60M |
| December 31, 1986 | 6.40M |
| December 31, 1985 | 15.10M |
| December 31, 1984 | 22.90M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
9.836B
Minimum
2023
14.38B
Maximum
2019
11.76B
Average
10.98B
Median
2021
Revenue (Annual) Benchmarks
| Eli Lilly and Co | 34.12B |
| Sage Therapeutics Inc | 86.46M |
| Pfizer Inc | 58.50B |
| Amgen Inc | 28.19B |
| Ionis Pharmaceuticals Inc | 787.65M |